Skip to main content

Main menu

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
  • Other Publications
    • The Journal of Applied Laboratory Medicine

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
Clinical Chemistry
  • Other Publications
    • The Journal of Applied Laboratory Medicine
  • Subscribe
  • My alerts
  • Log in
Clinical Chemistry

Advanced Search

  • Home
  • About
    • Clinical Chemistry
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
    • CE Credits
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Resources
    • AACC Learning Lab
    • Clinical Chemistry Trainee Council
    • Clinical Case Studies
    • Clinical Chemistry Guide to Scientific Writing
    • Clinical Chemistry Guide to Manuscript Review
    • Journal Club
    • Podcasts
    • Q&A
    • Translated Content
  • Abstracts
  • Submit
  • Contact
OtherLetters to the Editor

Are Glucokinase Mutations Associated with Low Triglycerides?

Mario Berger, Detlev Mönks, Henriette Schmidt, Vera Krane, Christoph Wanner, Ulrich Walter, Tom H. Lindner
DOI: 10.1373/clinchem.2004.045963 Published March 2005
Mario Berger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Detlev Mönks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henriette Schmidt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vera Krane
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Wanner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrich Walter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom H. Lindner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    Glucokinase mutations in families D_0000_7302 (A; A232D) and Dresden-7 (B; V154fsdelTG).

    Black-shaded symbols represent MODY2 patients. Individuals 0206 (A) and I.2 (B) had classic type 2 diabetes but were not MODY2 cases (dark-gray-shaded symbols). Individual 0305 (A) was a mutation carrier for A232D but had no clinical signs of type 2 diabetes (light-gray-shaded symbol). MN in circles/rectangles indicates a heterozygous mutation; NN indicates the wild-type genotype. Genotyped microsatellite markers on chromosome 7 are given on the left. The disease haplotype is shown in black. The sequence with the mutation (exon 7, forward strand) is shown for individual 0305 and the wild-type sequence for individual 0306. The location of the glucokinase gene is indicated by an arrow in the haplotype of individual 0401. CA/AM, current age/age at manifestation; BMI, body mass index; T2D, type 2 diabetes; OHA, oral hypoglycemic agents; CHD, coronary heart disease; GD, gestational diabetes; NE, diabetic neuropathy; FF, fenofibrate therapy.

PreviousNext
Back to top

In this issue

Clinical Chemistry: 51 (4)
Vol. 51, Issue 4
April 2005
  • Table of Contents
  • Index by author
Print
Share
Are Glucokinase Mutations Associated with Low Triglycerides?
Mario Berger, Detlev Mönks, Henriette Schmidt, Vera Krane, Christoph Wanner, Ulrich Walter, Tom H. Lindner
Clinical Chemistry Apr 2005, 51 (4) 791-793; DOI: 10.1373/clinchem.2004.045963
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Are Glucokinase Mutations Associated with Low Triglycerides?
Mario Berger, Detlev Mönks, Henriette Schmidt, Vera Krane, Christoph Wanner, Ulrich Walter, Tom H. Lindner
Clinical Chemistry Apr 2005, 51 (4) 791-793; DOI: 10.1373/clinchem.2004.045963

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • To the Editor:
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Long Reads, Short Time: Feasibility of Prenatal Sample Karyotyping by Nanopore Genome Sequencing
  • Hide and Seek: Overcoming the Masking Effect of Opioid Antagonists in Activity-Based Screening Tests
  • In Reply
Show more Letters to the Editor

Similar Articles

Subjects

  • SUBJECT AREAS
    • Lipids, Lipoproteins, and Cardiovascular Risk Factors
    • Molecular Diagnostics and Genetics
    • Endocrinology and Metabolism

Options

  • Home
  • About
  • Articles
  • Information for Authors
  • Resources
  • Abstracts
  • Submit
  • Contact
  • RSS

Other Publications

  • The Journal of Applied Laboratory Medicine
Footer logo

© 2019 American Association for Clinical Chemistry

Powered by HighWire